|
Materials and methods useful to induce vacuolization, cell death, or a combination thereof |
|
Materials and Methods Useful to Induce Vacuolization, Cell Death, or a Combination Thereof |
|
Materials and methods useful to induce cell death via methuosis |
|
Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use |
|
Epithiolone analogues |
|
Neural network system and uses thereof |
|
Improving efficacy of cancer therapy |
|
Aldose-ketose transformation for separation and/or chemical conversion of C6 and C5 sugars from biomass materials |
|
Polymeric ionic liquids, methods of making and methods of use thereof |
|
Treatment of cancers with A-8R peptide |
|
Catalysts and related processes for producing optically pure beta-lactones from aldehydes and compositions produced thereby |
|
Robust high temperature sulfur sorbents and methods of making the same |
|
Na/K-ATPase-derived peptide Src inhibitors and ouabain antagonists and uses thereof |
|
Methods and devices for detecting unsaturated compounds |
|
Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof |
|
Photovoltaic structures having a light scattering interface layer and methods of making the same |
|
Na/K-ATPase ligand |
|
Unfiltered radiation therapy |
|
HB No. 573 |
|
Foundation minutes |
